S558-0241 Screening compound: N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide

S558-0241 Screening compound: N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide
S558-0241 Screening compound: N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S558-0241
N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S558-0241

Molecular Formula

C24H20FN5O3 (C24 H20 FN5 O3)

Compound Name

N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide

IUPAC name

N-(2-fluorophenyl)-3-{2-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]phenoxy}pyrrolidine-1-carboxamide

SMILES

O=C(Nc(cccc1)c1F)N(CC1)CC1Oc(cccc1)c1-c1nc(-c2ccncc2)no1

InChI

InChI=1S/C24H20FN5O3/c25-19-6-2-3-7-20(19)27-24(31)30-14-11-17(15-30)32-21-8-4-1-5-18(21)23-28-22(29-33-23)16-9-12-26-13-10-16/h1-10,12-13,17H,11,14-15H2,(H,27,31)/t17-/m1/s1

InChI Key

HXZPNQJRRWFTMN-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD31960855

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.45

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.157

Distribution Coefficient, logD

4.157

Water Solubility, LogSw

-4.24

Polar Surface Area

72.491

Acid Dissociation Constant (pKa)

12.14

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.67

S558-0241 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S558-0241 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S558-0241?
Check Price and Availability of S558-0241, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S558-0241 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S558-0241
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S558-0241
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S558-0241 available by request